Pharming Group Nv earnings were -$16.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PHAR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$16.0M, down 637.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PHAR reported annual earnings of -$12.3M, with 5.2% growth.
What were Pharming Group Nv's earnings last quarter?
On PHAR's earnings call on Invalid Date, Pharming Group Nv (NASDAQ: PHAR) reported Q1 2025 earnings per share (EPS) of -$0.24, up 15.46% year over year. Total PHAR earnings for the quarter were -$16.00 million. In the same quarter last year, Pharming Group Nv's earnings per share (EPS) was -$0.21.
As of the last Pharming Group Nv earnings report, Pharming Group Nv is currently losing money. Pharming Group Nv's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$15.34 million, a 30.81% increase year over year.
What was PHAR's earnings growth in the past year?
As of Pharming Group Nv's earnings date in Invalid Date, Pharming Group Nv's earnings has grown year over year. PHAR earnings in the past year totalled -$16.04 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.